Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
HIF-1α: a master regulator of innate host defenses?
Kol A. Zarember, Harry L. Malech
Kol A. Zarember, Harry L. Malech
Published July 1, 2005
Citation Information: J Clin Invest. 2005;115(7):1702-1704. https://doi.org/10.1172/JCI25740.
View: Text | PDF
Commentary

HIF-1α: a master regulator of innate host defenses?

  • Text
  • PDF
Abstract

In the days following infection, when the human body develops and refines antibodies and prepares to mount an adaptive immune response, the bulwark of innate host defense against microbial infection is the polymorphonuclear leukocyte (PMN). PMNs seek out, identify, engulf, and sterilize invading microbes using both O2-dependent and O2-independent antimicrobial systems. A decrease in PMN numbers or function caused by immunosuppression or disease increases the risk of infection. In this issue of the JCI, Peyssonnaux et al. identify a novel and essential role for hypoxia-inducible factor–1α in regulating several important PMN functions relevant to host defense, including transcription of cationic antimicrobial polypeptides and induction of NO synthase.

Authors

Kol A. Zarember, Harry L. Malech

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
HIF-1α regulates several important PMN functions relevant to host defens...
HIF-1α regulates several important PMN functions relevant to host defense during both normoxia and hypoxia. (A) During normoxia, O2-dependent proline hydroxylases modify HIF-1α proline residues 402 and 564. Asparagine 803 is hydroxylated by FIH, which decreases HIF-1α interaction with the p300/CBP transcriptional coactivators. The hydroxylated prolines are recognized by vHL, a component of a ubiquitin ligase complex that ubiquitinates (Ub) HIF-1α and thereby targets it for proteosomal degradation. (B) During hypoxia and/or bacterial infection, when proline hydroxylases are not active, HIF-1α regulates transcription at HREs by accumulating and binding to HIF-1β and p300/CBP, which results in transcription of hypoxia-inducible genes involved in angiogenesis, glucose transport and metabolism, erythropoiesis, inflammation, apoptosis, and cellular stress. EPO, erythropoietin.

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts